<DOC>
	<DOCNO>NCT00235144</DOCNO>
	<brief_summary>The main objective study assess safety effectiveness sirolimus-coated Bx VELOCITY™ stent maintain minimum lumen diameter de novo native coronary artery lesion compare uncoated Bx VELOCITY balloon-expandable stent . Both stent mount Raptor® Rapid Exchange Stent Delivery System .</brief_summary>
	<brief_title>The Study BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions .</brief_title>
	<detailed_description>This multicenter ( 35 center ) , prospective , randomize double blind study . This study 2-arm design assess safety effectiveness sirolimus-coated Bx VELOCITY stent uncoated Bx VELOCITY stent , mount Raptor Rapid Exchange Stent Delivery System . A total 350 patient enter study randomize 1:1 basis . Patients either randomized sirolimus coat uncoated BX-VELOCITY stent . Patients follow 30 day , 6 , 9 , 12 month , 2 , 3 , 4 , 5 , 6 , 7 , 8 year post-procedure , patient undergo repeat angiography 8 month . Medical resource use 5 year follow-up period collect analyzed .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1 . Diagnosis angina pectoris define Canadian Cardiovascular Society Classification ( CCS I , II , III , IV ) OR unstable angina pectoris ( Braunwald Classification B &amp; C , III ) OR patient document silent ischemia ; 2 . Treatment single de novo native coronary artery lesion major coronary artery patient single multivessel disease ; patient multiple lesion include lesion require treatment ; 3 . Target vessel diameter lesion site &gt; =2.50mm &lt; =3.0mm diameter ( visual estimate ) ; 4 . Target lesion &gt; =15mm &lt; =32mm length ( visual estimate ) ; 5 . Target lesion stenosis &gt; 50 % &lt; 100 % ( visual estimate ) ; 1 . Patient experience Qwave nonQwave myocardial infarction document total CK &gt; 2 time normal within precede 24 hour CK CKMB enzymes remain normal time treatment ; 2 . Has unstable angina classified Braunwald III B C A IIIIII , peri infarction ; 3 . Unprotected leave main coronary disease &gt; =50 % stenosis ; 4 . Significant ( &gt; 50 % ) stenoses proximal distal target lesion might require revascularization impede runoff ; 5 . Have ostial target lesion ; 6 . Angiographic evidence thrombus within target lesion ; 7 . Heavily calcified lesion and/or calcify lesion successfully predilated ; 8 . Documented leave ventricular ejection fraction &lt; =25 % ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
</DOC>